AKR1B1 and kidney disorder: AKR1B1 or human aldose reductase mediates the first step in the reduction of glucose to sorbitol in the polyol pathway, which under hyperglycemic conditions is co-responsible for the diabetic complications (i.e., retinopathy, neuropathy, nephropathy, cataract) [158].